Mate1 Substrates + Capmatinib Interaction
Moderateinteraction on record
Description
Coadministration may increase MATE1 substrate exposure, which may increase adverse reactions. Decrease substrate dosage if coadministration unavoidable and minimal concentration changes may lead to serious reactions.
Mechanism
TABRECTA may inhibit MATE1, increasing substrate exposure
Source: NLP:capmatinib